PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of …
V Fragoulakis, G Kourlaba… - Value in Health, 2011 - valueinhealthjournal.com
Objectives To evaluate common therapeutic alternatives (rosuvastatin, atorvastatin,
simvastatin, pravastatin) for the prevention of primary and secondary cardiovascular events …
simvastatin, pravastatin) for the prevention of primary and secondary cardiovascular events …
[引用][C] PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary …
V Fragoulakis, G Kourlaba, N Maniadakis - Value in Health, 2011 - infona.pl
PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin
in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease …
in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease …